PRIEBE WALDEMAR has a total of 16 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are HANGZHOU HERTZ PHARMACEUTICAL CO LTD, THERACOS INC and CV THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Heterocyclic compounds | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Priebe Waldemar | 16 |
#2 | Fokt Izabela | 13 |
#3 | Madden Timothy | 7 |
#4 | Conrad Charles | 7 |
#5 | Perez-Soler Roman | 6 |
#6 | Przewloka Teresa | 5 |
#7 | Szymanski Slawomir | 4 |
#8 | Chaires Jonathan B | 3 |
#9 | Skora Stanislaw | 3 |
#10 | Skibicki Piotr | 3 |
Publication | Filing date | Title |
---|---|---|
US2012276108A1 | Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases | |
US2010152143A1 | Methods of treating skin disorders with caffeic acid analogs | |
US2011053992A1 | Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs) | |
AU5095800A | Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics | |
AU2539797A | Bis-anthracyclines with high activity against doxorubicin resistant tumors |